Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • papori
    Senior Member
    • Dec 2010
    • 181

    #1

    trans abyss assembly

    hey all, i am using trans abyss for de novo assembly.
    When i am running the assembly level for k=26(example) i am getting this kind of output:

    >11 3814 208317 9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+
    CTTGGTGAATTGGCTCCCGAAGCTCCTGCTGCTTGGAGTGGGTGACCT......

    can anyone explain me What does the numbers in the " > " line means?


    thanks in advance...
  • burt
    Junior Member
    • Jan 2011
    • 8

    #2
    Hey, I've been playing around with trans-abyss for RNA-seq data. Erm, what mode/stage of trans-abyss did you ran? I don't seem to remember coming across those kind of output for trans-abyss.

    In fact trans-abyss has a specific output folder for each stage of the pipeline. This is described in the flow diagram of the trans-abyss pipeline in their paper.

    Comment

    • papori
      Senior Member
      • Dec 2010
      • 181

      #3
      thanks mate, i got the answer already in trans abyss group..

      For this line:

      >11 3814 208317 9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+
      It means this contig ID is 11, its length is 3814, its kmer coverage is 208317, and the final string "9+,0+,5-,0+,5-,0+,5-,0+,5-,0+,2+" is the path of contig nodes that made up this contig.
      Rong

      Comment

      • blindtiger454
        Member
        • Oct 2010
        • 30

        #4
        it's a little off subject, but I've been curious about using trans abyss. How does the program output transcript variants of the same gene? Newbler uses the isogroup & isotig style, and I've heard velvet/oases uses a similar description. Can trans abyss do the same thing, labeling at the transcript and gene level?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          Yesterday, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 02:55 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...